Subclinical Synovitis Risk Higher in Psoriasis Without Musculoskeletal Involvement

Follow Drugslib on

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on July 22, 2025.

via HealthDay

TUESDAY, July 22, 2025 -- Subclinical synovitis is significantly more common among patients with psoriasis without musculoskeletal involvement than healthy controls, according to a review published online July 16 in JAMA Dermatology.

Shanti Mehta, from the University of Toronto, and colleagues conducted a systematic literature review and meta-analysis to evaluate the prevalence of synovitis on ultrasonograms and magnetic resonance imaging (MRI) among patients with psoriasis without musculoskeletal involvement.

Based on data from 12 studies (1,593 patients with psoriasis, 327 patients with psoriatic arthritis, and 686 healthy controls), the researchers found that synovitis was significantly more likely among patients with psoriasis than controls (risk ratio, 2.55; 95 percent confidence interval, 1.18 to 5.52). Compared with ultrasonography (risk ratio, 2.50; 95 percent confidence interval, 1.10 to 5.67), detection rates were higher with MRI (risk ratio, 6.40; 95 percent confidence interval, 1.87 to 21.95). While not statistically significant, synovitis was more frequent among patients with psoriatic arthritis than those with psoriasis (risk ratio, 0.50; 95 percent confidence interval, 0.13 to 1.87).

"This study suggests that subclinical synovitis is more prevalent among patients with psoriasis without musculoskeletal involvement than healthy controls, suggesting that imaging may help identify those at increased risk of transition to psoriatic arthritis," the authors write.

One author disclosed ties to AbbVie, Janssen, Novartis, Sandoz, and Amgen.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-07-23 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords